Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 48Gastrointestinal Stromal Tumors 26Leukemia 20Leukemia, Myeloid, Chronic-Phase 15Philadelphia Chromosome 9Leukemia, Myeloid 8Bone Marrow Diseases 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Hematologic Neoplasms 4Hematologic Diseases 4Blast Crisis 4Myeloproliferative Disorders 3Leukemia, Myeloid, Acute 3Hypereosinophilic Syndrome 3Glioblastoma 3Digestive System Neoplasms 3Bronchiolitis Obliterans Syndrome 3Recurrence 2Prostatic Neoplasms 2Neurofibrosarcoma 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Leukemia, Myeloid, Accelerated Phase 2Dermatofibrosarcoma 2Chordoma 2Brain Neoplasms 2Adenocarcinoma 2Urogenital Neoplasms 1

Interventions

Rituximab 8dacetuzumab 5blinatumomab 5ibrutinib 3Cyclophosphamide 3tetulomab tetraxetan lu-177 2ponatinib 2cobomarsen 2acalabrutinib 2Vincristine 2Prednisone 2Lutetium 2Ifosfamide 2Everolimus 2Etoposide 2Doxorubicin 2Carboplatin 2venetoclax 1sepantronium 1pomalidomide 1obinutuzumab 1fludarabine 1ficlatuzumab 1enzalutamide 1durvalumab 1denileukin diftitox 1cirmtuzumab 1amonafide 1Vorinostat 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Lymphatic Diseases × Imatinib Mesylate × Clear all
NCT01650805 2014-11-17

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Ariad Pharmaceuticals

Phase 3 Terminated
307 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡